Published in J Immunol on March 20, 2013
Integrated analyses of zebrafish miRNA and mRNA expression profiles identify miR-29b and miR-223 as potential regulators of optic nerve regeneration. BMC Genomics (2015) 0.80
MicroRNAs: The Role in Autoimmune Inflammation. Acta Naturae (2016) 0.78
Traumatic brain injury increases levels of miR-21 in extracellular vesicles: implications for neuroinflammation. FEBS Open Bio (2016) 0.77
Effects of exposure to Streptococcus iniae on microRNA expression in the head kidney of genetically improved farmed tilapia (Oreochromis niloticus). BMC Genomics (2017) 0.75
Is It worth Considering Circulating microRNAs in Multiple Sclerosis? Front Immunol (2016) 0.75
Pathogenic mechanism of miR-21 in autoimmune lymphoid hyperplasia syndrome. Oncol Lett (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
The functions of animal microRNAs. Nature (2004) 64.85
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res (2010) 25.85
Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature (2010) 22.04
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell (2006) 14.70
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med (2008) 12.90
miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell (2007) 9.08
Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med (1998) 7.24
A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods (2006) 7.00
MicroRNAs: new regulators of immune cell development and function. Nat Immunol (2008) 6.96
JAK-STAT signaling: from interferons to cytokines. J Biol Chem (2007) 5.28
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J (2010) 5.04
Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev (2007) 4.79
Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods (2009) 4.34
MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med (2010) 4.24
miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A (2007) 4.15
MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One (2007) 3.96
Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene (2006) 3.51
MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol (2009) 3.48
MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum (2009) 3.44
Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther (2008) 3.44
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A (2011) 3.37
Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A (2009) 3.27
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97
miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments. Nucleic Acids Res (2009) 2.90
Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature (2005) 2.89
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain (2009) 2.74
Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature (2002) 2.68
Environmental factors and multiple sclerosis. Lancet Neurol (2008) 2.66
miRanalyzer: an update on the detection and analysis of microRNAs in high-throughput sequencing experiments. Nucleic Acids Res (2011) 2.25
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One (2009) 2.14
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol (1994) 2.03
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus (2007) 2.03
Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One (2009) 1.98
Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J Immunol (2011) 1.93
CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity (2012) 1.85
Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology (2012) 1.78
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett (2011) 1.64
MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol (2010) 1.59
Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J Neuroimmunol (2010) 1.53
B cells and antibodies in CNS demyelinating disease. J Neuroimmunol (2001) 1.50
Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol (1993) 1.50
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One (2010) 1.49
Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum (2011) 1.46
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult Scler (2010) 1.46
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol (2010) 1.44
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain (2011) 1.27
pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res (2006) 1.15
Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology (1990) 1.15
Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci Lett (2011) 1.15
Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep (2012) 1.14
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One (2011) 1.10
The emerging role of microRNAs in multiple sclerosis. Nat Rev Neurol (2010) 1.08
Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol (2008) 1.06
Apoptosis of myelin-reactive T cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell Immunol (1997) 1.06
MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene (2012) 1.04
Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clin Immunol (2012) 1.04
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J Neuroimmunol (2008) 1.01
Prediction and validation of microRNA targets in animal genomes. J Biosci (2007) 0.96
Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol (2002) 0.93
MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur J Immunol (2012) 0.89
Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays. PLoS One (2009) 0.88
Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis. Autoimmunity (2010) 0.85
Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J Neuroimmunol (2009) 0.85
The development of autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein is associated with an upregulation of both proinflammatory and immunoregulatory cytokines in the central nervous system. J Interferon Cytokine Res (1998) 0.81
MOG(35-55) i.v suppresses experimental autoimmune encephalomyelitis partially through modulation of Th17 and JAK/STAT pathways. Eur J Immunol (2009) 0.81
Characterization of the encephalitogenic immune response in a model of multiple sclerosis. Eur J Immunol (2008) 0.77
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One (2007) 3.96
MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol (2008) 3.32
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med (2012) 2.81
IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol (2006) 2.39
MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nat Genet (2005) 2.32
An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform. Epigenetics (2013) 2.28
The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J Invest Dermatol (2008) 2.23
MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31. Int J Cancer (2009) 2.06
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect (2006) 1.91
Hemese, a hemocyte-specific transmembrane protein, affects the cellular immune response in Drosophila. Proc Natl Acad Sci U S A (2003) 1.79
Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol (2005) 1.76
Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res (2011) 1.70
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc Natl Acad Sci U S A (2010) 1.49
The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs. Nat Cell Biol (2009) 1.48
Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals. AIDS (2014) 1.47
Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet (2008) 1.47
microRNAs in inflammation. Int Rev Immunol (2009) 1.45
MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J Biol Chem (2012) 1.39
CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol (2005) 1.37
MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol (2010) 1.32
Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes. J Invest Dermatol (2010) 1.31
Combined sequence-based and genetic mapping analysis of complex traits in outbred rats. Nat Genet (2013) 1.30
MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol (2011) 1.26
Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes (2012) 1.25
Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. J Biol Chem (2005) 1.24
Mutational analysis of the poly(ADP-ribosyl)ation sites of the transcription factor CTCF provides an insight into the mechanism of its regulation by poly(ADP-ribosyl)ation. Mol Cell Biol (2009) 1.14
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. Breast Cancer Res (2009) 1.10
Effect of HIV-2 infection on HIV-1 disease progression and mortality. AIDS (2014) 1.08
MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol (2012) 1.07
Fuel use and metabolic response to endurance exercise: a wind tunnel study of a long-distance migrant shorebird. J Exp Biol (2002) 1.06
The expression of microRNA-203 during human skin morphogenesis. Exp Dermatol (2010) 1.04
miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma. Carcinogenesis (2013) 1.01
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Infect Genet Evol (2009) 1.01
Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists. Stem Cells Dev (2011) 1.00
IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation. J Immunol (2010) 0.99
Chemokines and chemokine receptors: new actors in neuroendocrine regulations. Front Neuroendocrinol (2010) 0.98
Flying saucer1 is a transmembrane RING E3 ubiquitin ligase that regulates the degree of pectin methylesterification in Arabidopsis seed mucilage. Plant Cell (2013) 0.97
MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. Exp Dermatol (2012) 0.96
RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol (2013) 0.96
Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats. PLoS One (2012) 0.95
Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med (2012) 0.92
Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis. J Neuroimmunol (2003) 0.92
Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J Immunol (2006) 0.91
Epigenetics: a new link between nutrition and cancer. Nutr Cancer (2013) 0.91
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Res (2013) 0.90
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration. Int J Cancer (2009) 0.90
Search for an aetiological virus candidate in chronic lymphocytic leukaemia by extensive transcriptome analysis. Br J Haematol (2012) 0.90
Characterization of EGFR and ErbB2 expression in atopic dermatitis patients. Arch Dermatol Res (2012) 0.89
Alternative splicing and transcriptome profiling of experimental autoimmune encephalomyelitis using genome-wide exon arrays. PLoS One (2009) 0.88
Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3. J Infect Dis (2013) 0.87
Maternal MHC regulates generation of pathogenic antibodies and fetal MHC-encoded genes determine susceptibility in congenital heart block. J Immunol (2010) 0.87
Cytokine responses during chronic denervation. J Neuroinflammation (2005) 0.86
Molecular and genetic diversity in the metastatic process of melanoma. J Pathol (2014) 0.86
Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. J Invest Dermatol (2007) 0.85
Characterization of Multiple Sclerosis candidate gene expression kinetics in rat experimental autoimmune encephalomyelitis. J Neuroimmunol (2009) 0.85
TNF production in macrophages is genetically determined and regulates inflammatory disease in rats. J Immunol (2010) 0.84
Advanced intercross line mapping suggests that ncf1 (ean6) regulates severity in an animal model of guillain-barre syndrome. J Immunol (2009) 0.84
Serum levels of LIGHT in MS. Mult Scler (2012) 0.84
Melanoma risk is associated with vitamin D receptor gene polymorphisms. Melanoma Res (2014) 0.83
Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates. Neurosci Lett (2003) 0.83
Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis. Genetics (2005) 0.83
MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. J Clin Invest (2015) 0.83
Genetics of autoimmune neuroinflammation. Curr Opin Immunol (2006) 0.83
MicroRNAs in inflammation and response to injuries induced by environmental pollution. Mutat Res (2011) 0.83
Fine-mapping resolves Eae23 into two QTLs and implicates ZEB1 as a candidate gene regulating experimental neuroinflammation in rat. PLoS One (2010) 0.82
Non-coding antisense transcription detected by conventional and single-stranded cDNA microarray. BMC Genomics (2007) 0.82
The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development. J Exp Med (2011) 0.81
Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin. J Invest Dermatol (2004) 0.81
The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes. Exp Dermatol (2006) 0.81
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch. Infect Genet Evol (2013) 0.81
Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage. Exp Neurol (2013) 0.81
Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma. Otolaryngol Head Neck Surg (2011) 0.81
Assessing the consistency of public human tissue RNA-seq data sets. Brief Bioinform (2015) 0.80
Interleukin-8 is regulated by miR-203 at the posttranscriptional level in primary human keratinocytes. Eur J Dermatol (2013) 0.80
Definition of a 1.06-Mb region linked to neuroinflammation in humans, rats and mice. Genetics (2006) 0.80
Identification of gene regions regulating inflammatory microglial response in the rat CNS after nerve injury. J Neuroimmunol (2009) 0.79
Identification of candidate risk gene variations by whole-genome sequence analysis of four rat strains commonly used in inflammation research. BMC Genomics (2014) 0.79
Human cytomegalovirus infection is sensitive to the host cell DNA methylation state and alters global DNA methylation capacity. Epigenetics (2012) 0.79
Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis. Mult Scler (2010) 0.78
Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders. PLoS One (2011) 0.78
Are BIC (miR-155) polymorphisms associated with eczema susceptibility? Acta Derm Venereol (2013) 0.78
Constraints for monocyte-derived dendritic cell functions under inflammatory conditions. Eur J Immunol (2011) 0.78
Effects of long term NOS inhibition on disease and the immune system in MOG induced EAE. Nitric Oxide (2005) 0.77
Human adult epidermal melanocytes cultured without chemical mitogens express the EGF receptor and respond to EGF. Arch Dermatol Res (2007) 0.77
Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity. Hum Mol Genet (2013) 0.77
Negative regulatory effect of histamine in DNFB-induced contact hypersensitivity. Int Immunol (2004) 0.77
A silent exonic SNP in kdm3a affects nucleic acids structure but does not regulate experimental autoimmune encephalomyelitis. PLoS One (2013) 0.77
Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice. J Immunol (2006) 0.76
Promoter usage of BRCA1-IRIS. Nat Cell Biol (2005) 0.76
Activation of toll-like receptors alters the microRNA expression profile of keratinocytes. Exp Dermatol (2014) 0.76
The nobel prize in physiology or medicine 2013. Vojnosanit Pregl (2013) 0.75
Genetic Polymorphisms of Catechol-O-Methyltransferase: Association with Temporomandibular Disorders and Postoperative Pain. J Oral Facial Pain Headache (2016) 0.75